ADMA Biologics
ADMA
#4079
Rank
S$3.81 B
Marketcap
S$17.20
Share price
-1.62%
Change (1 day)
-17.41%
Change (1 year)

Earnings for ADMA Biologics (ADMA)

Earnings in 2026 (TTM): S$0.31 Billion

According to ADMA Biologics 's latest financial reports the company's current earnings are S$0.51 Billion. In 2025 the company made an earning of S$0.24 Billion, an increase over its 2024 earnings that were of S$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ADMA Biologics from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.31 B28.68%
2025 S$0.24 B35.89%
2024 S$0.18 B-4446.66%
2023 -S$4.15 Million-93.11%
2022 -S$60.13 Million-20.42%
2021 -S$75.56 Million-8.11%
2020 -S$82.23 Million62.31%
2019 -S$50.67 Million-34.76%
2018 -S$77.66 Million48.79%
2017 -S$52.2 Million134.28%
2016 -S$22.28 Million7.12%
2015 -S$20.8 Million0.3%
2014 -S$20.74 Million7.85%
2013 -S$19.23 Million71.04%
2012 -S$11.25 Million28864%
2011 -S$0.04 Million35.22%
2010 -S$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
S$39.56 M-87.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-S$0.29 Billion-191.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$28.71 Million-109.08%๐Ÿ‡บ๐Ÿ‡ธ USA